Award

Investigation of the association between blood glucose variability and left ventricular diastolic dysfunction in high-precision continuous subcutaneous measurements

Description: In type 2 diabetic patients with some cardiac complications, treatment with an SGLT2 inhibitor, which has been shown to prevent HFpEF, resulted in a decrease in left ventricular end-diastolic diameter and an increase in flow-dependent vasodilatory response after 6 months.The study also showed a decrease in left ventricular end-diastolic diameter and an increase in flow-dependent vasodilation response after 6 months. In addition, a correlation was observed between improvement in left ventricular diastolic performance (E/e ratio) and increases in ketone bodies (acetoacetic acid and 3-hydroxybutyric acid), suggesting that the increase in ketone bodies caused by SGLT2 inhibitors is associated with improvement in left ventricular diastolic performance.Further studies will examine the relationship between sustained blood glucose levels and left ventricular end-diastolic diameter in type 2 diabetes mellitus.
Amount: ¥2,730,000
Funding type: fellowship
Funder scheme: Grant-in-Aid for Early-Career Scientists
Start date: 2018-04-01
End date: 2022-03-31
Investigator: MAYU TOCHIYA (lead)
Institution: National Cardiovascular Center Research Institute
Field: Medicine
Funded outputs count: 0
Funder award ID: 18K15436
OpenAlex ID: G4293155641